1807608-59-8: Linagliptin Impurity 43

Linagliptin Impurity 43 ( CAS No.1807608-59-8) is an impurity present in Linagliptin. Linagliptin is an inhibitor of DPP-4, It is an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide, which is used in the treatment of type-2 diabetes.

Additional information on CAS 1807608-59-8

Catalogue No.

VE009701

CAS No.

1807608-59-8

Molecular Formula

C25H28N8O3

Molecular Weight

488.6 g/mol

Parent drug

Linagliptin

IUPAC Name

(R)-8-(3-aminopiperidin-1-yl)-7-(4-hydroxybut-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3, 7-dihydro-1H-purine-2, 6-dione

Synonyms

N/A

References

"Freeman, M. K. (2011). Efficacy and safety of linagliptin (tradjenta) in adults with type-2 diabetes mellitus. P & T : A Peer-Reviewed Journal for Formulary Management, 36(12), 807–842. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278179/ "

Status

In-stock